Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY:TMO)

463.04 -4.64 (-0.99%)
Official Closing Price Updated: 6:30 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
P/E Ratio Insights for Thermo Fisher Scientific
 
Via Benzinga
Stay informed with the top movers within the S&P500 index on Wednesday.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session. 
Via Chartmill
Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030
Sanofi plans $20 billion US investment by 2030 to expand R&D and manufacturing, aiming to boost medicine production and job creation across states. 
Via Benzinga
What's going on in today's session: S&P500 movers
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
Earnings Scheduled For April 23, 2025
 
Via Benzinga
Earnings Preview For Thermo Fisher Scientific
 
Via Benzinga
Which S&P500 stocks are gapping on Wednesday?
Looking for the S&P500 stocks that are experiencing notable gaps on Wednesday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session. 
Via Chartmill
This Senator Just Sold Up To $700K In Thermo Fisher Scientific Stock
 
Via Benzinga
Thermo Fisher, Biogen, Gilead Sciences, Moderna, and QuidelOrtho Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years
 
Via Benzinga
3 S&P 500 Stocks in the Doghouse
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight
FDA to increase surprise inspections at foreign facilities as U.S. companies pour billions into domestic drug and device manufacturing. 
Via Benzinga
Thermo Fisher Scientific to Present at BofA Securities 2025 Health Care Conference on May 13
From Thermo Fisher Scientific Inc.
Via Business Wire
This Market Is The Buying Opportunity Of A Lifetime
 
Via Benzinga
3 Profitable Stocks Skating on Thin Ice
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
Is Thermo Fisher Scientific Gaining or Losing Market Support?
 
Via Benzinga
Tariffs Bite Dan Loeb's Portfolio: Thermo Fisher Hit Hard, Discover Shines
Year to date, Thermo Fisher fell about 21.03%, both underperforming the iShares U.S. Healthcare ETF, which declined about 2.36%. 
Via Benzinga
Topics ETFs
Revvity (RVTY) Q1 Earnings Report Preview: What To Look For
Life sciences company Revvity (NYSE:RVTY) will be reporting results tomorrow before market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Thermo Fisher Doubles Down On US Manufacturing In $2B Expansion Plan
Thermo Fisher plans $2 billion U.S. investment amid tariff concerns, while analysts lower price targets despite reaffirming positive ratings. 
Via Benzinga
Topics World Trade
3 Healthcare Stocks with Mounting Challenges
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the... 
Via StockStory
Topics Stocks
Thermo Fisher Scientific Invests to Enhance U.S. Innovation and Support Customers’ Manufacturing
From Thermo Fisher Scientific Inc.
Via Business Wire
Earnings To Watch: Avantor (AVTR) Reports Q1 Results Tomorrow
Life sciences company Avantor (NYSE:AVTR) will be reporting earnings tomorrow before market open. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence Economy World Trade
TMO Q1 Earnings Call: Navigating Tariffs and Macro Uncertainty While Investing in Innovation
Life sciences company Thermo Fisher (NYSE:TMO) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales were flat year on year at $10.36 billion. Its non-GAAP profit of $5.15 per... 
Via StockStory
Topics Economy World Trade
Thermo Fisher Beats Q1 Estimates, Lowers Full-Year Forecast As Tariffs And Costs Take A Toll
Thermo Fisher cut its 2025 EPS and revenue outlook due to tariffs and U.S. policy changes, expecting a $400 million sales hit and lower operating income. 
Via Benzinga
Topics World Trade
Thermo Fisher Reports Strong Q1 Earnings But Revises Full-Year Guidance In Light Of Trump Tariffs: Retail’s Pessimistic
The company now expects 2025 revenue to be in the range of $43.3 billion to $44.2 billion and adjusted EPS to be in the range of $21.76 to $22.84, compared with its previous forecast of $23.10 to... 
Via Stocktwits
Topics Earnings Government World Trade
Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What's Driving Markets Wednesday?
Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration helped lift investor confidence. 
Via Benzinga
Topics Government
Thermo Fisher Scientific Q1 Earnings Surpass Estimates, CEO Touts 'Strong Performance' Despite Economic Uncertainty
Thermo Fisher topped Q1 estimates with $5.15 EPS and $10.36 billion revenue, boosted by diagnostics and life sciences growth. 
Via Benzinga
Thermo Fisher (NYSE:TMO) Posts Better-Than-Expected Sales In Q1
Life sciences company Thermo Fisher (NYSE:TMO) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $10.36 billion. Its non-GAAP profit of $5.15... 
Via StockStory
Thermo Fisher Scientific Reports First Quarter 2025 Results
From Thermo Fisher Scientific Inc.
Via Business Wire
9 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.